Overall rank by patents
#42,534
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Radisens Diagnostics Limited
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, active 2016–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).
6
Total patents granted
5
CPC technology areas
12.5
Avg claims per patent
-50%
5-year filing velocity
The verdict
Radisens holds 6 US patents across 5 technology areas, rank #42,534 of 50,000 tracked assignees.
- #42,534
- of 50,000 US assignees by volume
- Top 83%
- by Innovation Score (25.5/100)
- 12.5
- avg claims per patent
- -50%
- filing velocity, last 5 yrs
Portfolio overview
Radisens Diagnostics Limited has been granted 6 US utility patents between 2016 and 2022, placing Radisens Diagnostics Limited at rank #42,534 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.5 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a Foreign Corporation, Radisens Diagnostics Limited is one of the more focused assignees in the PatentsView dataset. By volume, Radisens sits between R2 Semiconductor (6 patents, rank #42,530) and Rassini Frenos, S.a. DE C.v. (6 patents, rank #42,538) - the closest US assignees by grant volume. The composite Innovation Score of 25.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 4 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Radisens Diagnostics Limited's 12.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Radisens Diagnostics Limited against peers pursuing similar technology classes.
Who files at Radisens's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- R2 Semiconductor
R2 Semiconductor
6 patents
- Racyics
RACYICS GMBH
6 patents
- Radar
RADAR, LLC
6 patents
- Radiant Vision Sy…
RADIANT VISION SYSTEMS, LLC
6 patents
- RAM Group
RAM Group, Inc.
6 patents
- Ramun Korea
RAMUN KOREA CO., LTD.
6 patents
- Rapid Granulator…
RAPID GRANULATOR AB
6 patents
- Rassini Frenos DE…
RASSINI FRENOS, S.A. DE C.V.
6 patents
- Radisens Diagnost… ◀
RADISENS DIAGNOSTICS LIMITED
6 patents
What this shows Radisens holds 6 patents at rank #42,534, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Radisens
By rank, the assignees closest to #42,534 in granted patent volume.
- R2 Semiconductor #42,530 · 6 patents
- Racyics Gmbh #42,531 · 6 patents
- Radar, Llc #42,532 · 6 patents
- Radiant Vision Systems, Llc #42,533 · 6 patents
- RAM Group, Inc. #42,535 · 6 patents
- Ramun Korea Co., Ltd. #42,536 · 6 patents
- Rapid Granulator AB #42,537 · 6 patents
- Rassini Frenos, S.a. DE C.v. #42,538 · 6 patents
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Radisens's primary technology class.
- The Regents Of The University Of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson And Company 193 in class
- Bio-rad Laboratories, Inc. 174 in class
- President And Fellows Of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Radisens's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 83% higher than 17% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 16.7% |
| 2018 | 2 | 33.3% |
| 2019 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
Which technologies does Radisens Diagnostics Limited patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Radisens Diagnostics Limited hold?
Radisens Diagnostics Limited holds 6 US granted patents filed between 2016 and 2022, spanning 5 technology areas.
What is Radisens Diagnostics Limited's Innovation Score?
Radisens Diagnostics Limited has an Innovation Score of 25.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Radisens Diagnostics Limited focus on?
Radisens Diagnostics Limited's top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 5 patents. The company has filed patents in 5 CPC subclasses total.
Is Radisens Diagnostics Limited's patent filing rate increasing or decreasing?
Radisens Diagnostics Limited's recent filing velocity is -50% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Radisens Diagnostics Limited's patents?
Radisens Diagnostics Limited's patents average 12.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Radisens Diagnostics Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Radisens's 6 grants land it in the top 83% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Radisens ranks #42,534 of 50,000. Top 50 holders
- Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.